Tobacco and Nicotine Compliance North America: FDA PMTA 2026

In May 2026, U.S. Customs and Border Protection, the Coast Guard and the FDA announced Operation Red Mist: more than 18 million unauthorized vape units, worth over $175 million, seized from maritime cargo shipments tied to China. Every unit lacked FDA marketing authorization. Three months earlier, the FDA had told the industry it was deprioritizing enforcement against exactly the kind of e-cigarettes and nicotine pouches still waiting on a premarket decision, as long as their application was accepted and filed. Those two facts sitting side by side, aggressive port seizures and a formal lower-priority enforcement track, are the defining tension of tobacco and nicotine compliance in North America right now.

Meanwhile Canada's health minister still cannot say when, or whether, the flavoured vaping restrictions first promised in June 2021 will ever take effect, five years and counting. For a compliance team running products across the US-Canada border, the two countries are moving on almost opposite clocks: Washington is clearing a multi-year PMTA backlog while tightening import enforcement, and Ottawa has acted decisively on nicotine pouches but stalled indefinitely on vaping flavours.

Is the FDA's PMTA backlog actually cleared in 2026?

Largely yes, and the numbers back it up. FDA's Center for Tobacco Products has now acted on nearly 27 million premarket tobacco product applications submitted since 2020, and it cut the review backlog by roughly 70% during 2025 alone. The number of e-cigarette PMTAs still pending acceptance fell from 287,886 in fiscal year 2023 to 193,777 in fiscal year 2024 to just 33,486 in fiscal year 2025. FDA also says there is no longer a queue for Acceptance Review: a newly filed PMTA now enters that first phase almost immediately on receipt. The agency's nicotine pouch pilot, launched in September 2025 to accelerate scientific review, issued its first six marketing authorizations in December, three months after review began, which FDA calls a record turnaround for a PMTA decision.

What does FDA's May 2026 enforcement guidance actually change?

It replaces FDA's April 2020 ENDS enforcement policy with a narrower, status-based test. Under the May 8, 2026 final guidance, "Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization," FDA generally will not prioritize enforcement against an ENDS or nicotine pouch product if it is covered by a PMTA submitted on or after November 4, 2021 that has been accepted and filed, or by a qualifying supplemental PMTA accepted and pending for more than 180 days. For non-tobacco-flavored ENDS, the accepted application must also include the data needed to evaluate the public health standard. Critically, FDA is explicit that this creates no safe harbor: the product remains illegally marketed, and any presumptively youth-appealing feature, a cartoon character, packaging disguised as a toy or phone, a resemblance to a gaming device, keeps the product a prioritized enforcement target regardless of application status.

For compliance teams, the practical shift is that application status, not the age of a prior submission deadline, is now the operative test. A product with a stalled or Refuse-to-Accept application gets no benefit from this guidance. Tracking exactly where each SKU sits in FDA's review pipeline, and how that status changes month to month, is the kind of granular, primary-source monitoring that Obsidian's regulatory monitoring is built to keep current across an entire portfolio.

Why did the federal menthol cigarette ban disappear?

FDA proposed banning menthol as a characterizing flavor in cigarettes, and all characterizing flavors in cigars, in April 2022, drawing more than 175,000 public comments. The rule missed self-imposed deadlines in 2023 and 2024, and on January 21, 2025, the incoming administration's Office of Information and Regulatory Affairs formally listed both proposals as withdrawn. That ends the federal rulemaking, though either proposal could be revived by a future administration. In the meantime, several states and localities retain their own flavor restrictions on combustible tobacco, which means the compliance baseline for a national retailer or manufacturer is set state by state rather than by a single federal standard.

How aggressive is customs and retail enforcement against unauthorized vapes?

Very. Beyond Operation Red Mist's $175 million seizure, an earlier joint FDA-CBP operation intercepted close to $34 million in illegal e-cigarettes, almost all originating in China and mislabeled to obscure their value and contents, and FDA sent import informational letters to 24 tobacco importers and entry filers for the first time. Cumulatively, FDA has issued more than 750 warning letters to manufacturers and over 800 to retailers for unauthorized new tobacco products, and filed civil money penalty complaints against 87 manufacturers and more than 175 retailers.

Online and interstate sellers face a parallel obligation under the PACT Act: register with ATF using Form 5070.1, register separately with the tobacco tax administrator of every state shipped into, and file a delivery sales report with each of those states by the 10th of the following month, for example June 10, 2026 for May shipments. A seller shipping to 30 states files 30 separate monthly reports, and state-level tax penalties for fraudulent non-compliance can reach 50% of the tax owed. A single missed jurisdiction is a compliance gap that compounds every month it goes uncorrected.

Is Canada any closer to a national vaping flavour ban?

No. Health Canada first announced in June 2021 that it would restrict vaping flavours nationwide to mint, menthol and tobacco. Regulations were drafted and ready by 2024, but as of the government's own statements in 2026, the health minister still will not commit to a timeline, citing concerns that a ban could push consumers toward an illicit market. In the resulting vacuum, Quebec, the Northwest Territories, Nunavut, New Brunswick, Prince Edward Island and Nova Scotia have each enacted their own provincial or territorial flavour restrictions, leaving manufacturers and retailers to comply with a patchwork rather than a single federal rule.

Nicotine pouches tell the opposite story. Ottawa moved fast there: since August 28, 2024, pouches like Zonnic can only be sold from behind a pharmacy counter, dessert, confectionery, soft drink and energy drink flavours are banned outright, and only menthol and mint variants remain permitted at retail. Health Canada's companion Supplementary Rules Respecting Nicotine Replacement Therapies Order applies the same youth-appeal flavour restrictions to nicotine replacement products regulated separately under the Food and Drugs Act. For a company selling both vapes and pouches into Canada, tracking which product category is subject to which regime, and which regime actually has teeth, is not optional.

North America tobacco and nicotine, key 2025-2026 milestones

What should compliance teams track going into H2 2026?

Three tracks move independently and each carries real enforcement exposure: FDA's PMTA pipeline status for every SKU, the unresolved venue question left open by the Fifth Circuit's menthol-vape denial litigation that reached the Supreme Court, and Canada's stalled flavour rulemaking sitting next to its already-enforced pouch restrictions. None of these will be flagged by a general news alert; they surface in agency guidance documents, Federal Register notices, Canada Gazette orders and provincial bulletins that rarely reference each other.

This is precisely the gap Obsidian closes: tier-0 monitoring of FDA, ATF, Health Canada and provincial regulators in one place, with alerts the moment an enforcement guidance, a PMTA metric update or a provincial flavour rule changes. Teams already using Obsidian's AI query their own jurisdiction mix directly instead of re-reading agency PDFs line by line, and the same underlying data is available programmatically through the Obsidian MCP for teams wiring regulatory checks into their own workflows.

Whichever side of the border a portfolio sits on, the practical next step is the same: map every product to its actual application or authorization status today, not to the status it held six months ago, because in this sector six months is the difference between a cleared backlog and a customs seizure.